These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 39427177)
1. Lymph node ratio is a prognostic indicator for locally advanced gastric cancer after neoadjuvant immunochemotherapy. Zhou P; Sun X; Zeng L; Zeng X; Xie G; Liu X; Tao K; Zhang P BMC Gastroenterol; 2024 Oct; 24(1):371. PubMed ID: 39427177 [TBL] [Abstract][Full Text] [Related]
2. Lymph node ratio is a prognostic indicator for locally advanced esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy. Chen P; Wang L; Yang X; Feng J Biomol Biomed; 2024 Jan; 24(1):159-169. PubMed ID: 37597214 [TBL] [Abstract][Full Text] [Related]
3. Lymph node ratio is a prospective prognostic indicator for locally advanced gastric cancer patients after neoadjuvant chemotherapy. Jiang Q; Zeng X; Zhang C; Yang M; Fan J; Mao G; Shen Q; Yin Y; Liu W; Tao K; Zhang P World J Surg Oncol; 2022 Aug; 20(1):261. PubMed ID: 35978363 [TBL] [Abstract][Full Text] [Related]
4. [Clinical study on the effects of neoadjuvant chemotherapy on lymph node ratio, prognosis, and survival analysis of stage ⅢA-N2 non-small cell lung cancer]. Wei YL; Cui YH; Dong YH; Shi WJ Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(4):259-264. PubMed ID: 33486934 [No Abstract] [Full Text] [Related]
5. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection. Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003 [TBL] [Abstract][Full Text] [Related]
6. Lymph node ratio as best prognostic factor in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy. De la Cruz-Ku GA; Chambergo-Michilot D; Valcarcel B; Rebaza P; Möller M; Araujo JM; Enriquez D; Morante Z; Razuri C; Luque R; Saavedra A; Eyzaguirre E; Lujan M; Noel N; Pinto J; Cotrina J; Gomez H Breast J; 2020 Sep; 26(9):1659-1666. PubMed ID: 32713113 [TBL] [Abstract][Full Text] [Related]
7. The prognostic value of lymph node ratio for local advanced gastric cancer patients with adjuvant chemoradiotherapy after D2 gastrectomy. Hu M; Zhang S; Yang X; Shen Y; Li Z; Zhao Y; Xu F; Jiang D; Wang X; Wang Y Medicine (Baltimore); 2018 Nov; 97(44):e13079. PubMed ID: 30383693 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision. Zuo ZG; Zhang XF; Wang H; Liu QZ; Ye XZ; Xu C; Wu XB; Cai JH; Zhou ZH; Li JL; Song HY; Luo ZQ; Li P; Ni SC; Jiang L Medicine (Baltimore); 2016 Mar; 95(9):e2988. PubMed ID: 26945418 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of a pathological response in metastatic lymph nodes of patients with gastric cancer who underwent neoadjuvant chemotherapy followed by surgery. Chen F; Xian J; Huo J Surg Today; 2024 Oct; 54(10):1255-1264. PubMed ID: 38587668 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage. Shin K; Park SJ; Lee J; Park CH; Song KY; Lee HH; Seo HS; Jung YJ; Park JM; Lee SH; Roh SY; Kim IH BMC Cancer; 2019 Dec; 19(1):1232. PubMed ID: 31852475 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of residual nodal burden using lymph node ratio in locally advanced breast cancer after neoadjuvant chemotherapy. Agarwal R; Philip A; Pavithran K; Rajanbabu A; Goel G; Vijaykumar DK Indian J Cancer; 2019; 56(3):228-235. PubMed ID: 31389386 [TBL] [Abstract][Full Text] [Related]
12. Association Between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer. Kano K; Yamada T; Yamamoto K; Komori K; Watanabe H; Hara K; Shimoda Y; Maezawa Y; Fujikawa H; Aoyama T; Tamagawa H; Yamamoto N; Cho H; Shiozawa M; Yukawa N; Yoshikawa T; Morinaga S; Rino Y; Masuda M; Ogata T; Oshima T Ann Surg Oncol; 2020 Oct; 27(11):4235-4247. PubMed ID: 32424582 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of metastatic lymph node ratio in gastric cancer: a Western-center analysis. Ergenç M; Uprak TK; Akın Mİ; Hekimoğlu EE; Çelikel ÇA; Yeğen C BMC Surg; 2023 Aug; 23(1):220. PubMed ID: 37550669 [TBL] [Abstract][Full Text] [Related]
14. Is there a survival difference between older adult and younger adult patients with locally advanced gastric cancer with the same lymph node ratio? Yalkin O; Iflazoglu N; Deniz O; Uzunoglu MY; Turhan EI J Geriatr Oncol; 2022 Sep; 13(7):962-969. PubMed ID: 35739052 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Lymph Node Ratio in Breast Cancer Patients with Adequate Pathologic Evidence After Neoadjuvant Chemotherapy. Ai X; Liao X; Wang M; Hu Y; Li J; Zhang Y; Tang P; Jiang J Med Sci Monit; 2020 Apr; 26():e922420. PubMed ID: 32348295 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of a modified pathological staging system for gastric cancer based on the number of retrieved lymph nodes and metastatic lymph node ratio. Jia G; Zhou D; Tang X; Liu J; Lei P PeerJ; 2024; 12():e18165. PubMed ID: 39372713 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer. Hou Y; Wang X; Chen J World J Surg Oncol; 2018 Oct; 16(1):198. PubMed ID: 30286762 [TBL] [Abstract][Full Text] [Related]
18. The Prognostic Value of Lymph Node Ratio in Locally Advanced Esophageal Cancer Patients Who Received Neoadjuvant Chemotherapy. Kano K; Yamada T; Komori K; Watanabe H; Takahashi K; Fujikawa H; Numata M; Aoyama T; Tamagawa H; Yukawa N; Rino Y; Masuda M; Ogata T; Oshima T Ann Surg Oncol; 2021 Dec; 28(13):8464-8472. PubMed ID: 34114182 [TBL] [Abstract][Full Text] [Related]
19. Lymph node ratio as an indicator of nodal status in the assessment of survival and recurrence in vulvar cancer: A cohort study. Mansouri H; Zemni I; Sakhri S; Ayadi MA; Boujelbene N; Ben Dhiab T Womens Health (Lond); 2024; 20():17455057241285396. PubMed ID: 39340307 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of fibrosis ratio in metastatic lymph nodes of node-positive advanced gastric cancer. Hong SA; Son MW; Cho J; Lee CH; Jang SH; Lee HJ; Lee JH; Cho HD; Oh MH; Lee KT; Lee MS Medicine (Baltimore); 2018 Jan; 97(3):e9703. PubMed ID: 29505025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]